Related news from
Tue, 21 Oct 2025 22:00:04 +0000	Hercules Capital (HTGC) Stock Moves 1.37%: What You Should Know Hercules Capital (HTGC) concluded the recent trading session at $17.73, signifying a +1.37% move from its prior day's close.
Mon, 20 Oct 2025 13:10:40 +0000	Viridian Therapeutics Signs $300 Million Royalty Financing Deal With DRI Healthcare Viridian Therapeutics (VRDN) said Monday it signed a royalty financing deal with DRI Healthcare Acqu
Mon, 20 Oct 2025 11:30:00 +0000	Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million WALTHAM, Mass., October 20, 2025--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potentially best-in-class medicines for serious and rare diseases, today announced it entered into a royalty financing agreement with DRI Healthcare Acquisitions LP (DRI) and accelerated its timelines for the submission of the veligrotug BLA and the topline clinical data readouts of its VRDN-003 REVEAL trials in patients with thyroid eye dis
Sun, 19 Oct 2025 23:04:44 +0000	Assessing Hercules Capital (HTGC) Valuation After Recent Share Price Volatility Hercules Capital (HTGC) has recently caught the attention of market watchers after experiencing some noticeable stock movement. While there is not a specific news event driving recent changes, investors continue to weigh the company's fundamentals and performance. See our latest analysis for Hercules Capital. After climbing earlier in the year, Hercules Capital’s share price has recently pulled back, now sitting at $17.27 following a 30-day share price return of -10.15%. Despite some...
Thu, 16 Oct 2025 10:00:00 +0000	Hercules Capital Announces Date for Release of Third Quarter 2025 Financial Results and Conference Call SAN MATEO, Calif., October 16, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2025 financial results conference call for Thursday, October 30, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules
Fri, 10 Oct 2025 04:50:20 +0000	3 Value Stocks with Open Questions Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Thu, 09 Oct 2025 22:15:05 +0000	Here's Why Hercules Capital (HTGC) Fell More Than Broader Market Hercules Capital (HTGC) closed the most recent trading day at $17.06, moving 3.67% from the previous trading session.
Thu, 09 Oct 2025 17:15:56 +0000	Why Hercules Capital (HTGC) Shares Are Sliding Today Shares of specialty finance company Hercules Capital (NYSE:HTGC) fell 2.8% in the afternoon session after analyst firm Piper Sandler lowered its price target on the stock. Analyst Crispin Love reduced the price target to $20.50 from a previous $21.00, representing a 2.38% decrease. While the firm maintained its "Overweight" rating on Hercules Capital, a lower price target can signal reduced expectations for a stock's future performance. This type of adjustment often influences investor sentiment
Thu, 09 Oct 2025 06:11:39 +0000	Is Hercules Capital a Bargain After This Year’s 13% Decline? If you're holding Hercules Capital stock or wondering if now is the right time to step in, you're not alone. Investors have been weighing the company’s latest price dips. For example, consider the nearly 9% slide in the last 30 days and a year-to-date performance that’s off by over 13%. It may feel a bit unsettling, but zoom out and you’ll see a much different story: over three and five years, Hercules Capital has delivered total returns of 104.6% and 156.2%, respectively. Those gains didn’t...
Tue, 07 Oct 2025 05:25:33 +0000	Exploring Hercules Capital’s (HTGC) Edge as a High-Yield BDC Dividend Stock Hercules Capital, Inc. (NYSE:HTGC) is included among the 11 Best BDC Stocks to Buy Now. Hercules Capital, Inc. (NYSE:HTGC) is a financing firm based in California that lends mainly to fast-growing companies backed by venture capital or big institutional investors. Most of what it does involves senior secured loans across a range of industries, helping […]
Fri, 03 Oct 2025 22:00:03 +0000	Hercules Capital (HTGC) Stock Sinks As Market Gains: What You Should Know In the latest trading session, Hercules Capital (HTGC) closed at $18.4, marking a -1.87% move from the previous day.
Tue, 30 Sep 2025 04:03:31 +0000	Q2 Earnings Highs And Lows: Hercules Capital (NYSE:HTGC) Vs The Rest Of The Specialty Finance Stocks As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at specialty finance stocks, starting with Hercules Capital (NYSE:HTGC).
Mon, 29 Sep 2025 22:15:02 +0000	Hercules Capital (HTGC) Stock Slides as Market Rises: Facts to Know Before You Trade In the most recent trading session, Hercules Capital (HTGC) closed at $18.88, indicating a -1.2% shift from the previous trading day.
Sat, 27 Sep 2025 13:34:59 +0000	Why uniQure (QURE) Is Up After Positive AMT-130 Trial Results and Major New Funding Announcements uniQure N.V. recently announced positive topline results from its pivotal Phase I/II trial of AMT-130, demonstrating statistically significant slowing of Huntington's disease progression, and entered into a US$175 million senior secured term loan facility with Hercules Capital, alongside launching a US$200 million underwritten equity offering. The regulatory designations for AMT-130 and the implementation of non-dilutive debt financing, together with equity issuance, highlight both the...
Thu, 25 Sep 2025 13:30:03 +0000	Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet Based on the average brokerage recommendation (ABR), Hercules Capital (HTGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Thu, 25 Sep 2025 09:09:28 +0000	Tipalti secures $200M in financing The capital will be used for further AI investment as the finance automation fintech incorporates agentic artificial intelligence capabilities.
Wed, 24 Sep 2025 18:50:04 +0000	This Stock Is Tripling on a Key Gene Therapy Win. Should You Buy the 200%-Plus Surge Now? Uniqure shares skyrocket as the biotech firm announces a major breakthrough in Huntington’s disease. Here’s why investors should wait before initiating a new position in QURE stock.
Wed, 24 Sep 2025 14:23:24 +0000	uniQure Stock Doubles On Promising Data From Huntington's Disease Trial uniQure N.V. (NASDAQ:QURE) on Wednesday released topline data from the pivotal Phase 1/2 study of AMT-130 for Huntington’s disease. Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time. The disease affects a person’s movements, thinking ability and mental health. The study met its prespecified primary endpoint, with high-dose AMT-130 demonstrating a statistically significant slowing of disease progression as measured by the composite Unified Hunti
Wed, 24 Sep 2025 13:27:00 +0000	ARCC vs. HTGC: Which BDC Has More Upside as Rates Come Down? Does Hercules Capital's tech and life sciences focus, rising commitments and stronger earnings outlook give it an edge over Ares Capital? Let's decode.
Wed, 24 Sep 2025 13:00:00 +0000	Tipalti Secures $200 Million in Growth Financing to Drive Next Wave of AI Innovation in Finance Tipalti, the AI-powered platform for finance automation, today announced it has secured $200 million in growth financing from long-time partner Hercules Capital, Inc. (NYSE: HTGC). The financing will fuel Tipalti's continued investment in artificial intelligence (AI) and product innovation, as well as support its global growth.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like BDCs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!